Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 11512990Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2025
Linked Award Amount
$1.4M
Full award amounts, FY2025
Award Records
2
Records listing this PI
Award-Linked Rank
#10,705
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Andrew Michael Intlekofer as a PI. Multi-PI records show the full award amount for context.
- 4R37CA251543-06R37Metabolic control of normal and malignant hematopoiesis$964.1Kaward amount
- 5R01CA290231-02R01Targeting isocitrate dehydrogenase mutations by enzyme hyperactivation$474.8Kaward amount
Award organization
Organizations that administered FY2025 awards listing Andrew Michael Intlekofer as a PI.
FY2025 award administered by Memorial Sloan Kettering Cancer Center (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardMemorial Sloan Kettering Cancer Center
- 2024$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025$2M Cumulative Funding
- 2025R01 Grant Holder